Low
₹
High
₹
| Previous Close | |
|---|---|
| Day's Range | N/A - N/A |
| Open | |
| 52 Week Range | ₹43,806.95 - ₹47,764.30 |
| Volume |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Blue Star Ltd. | 1575.00 | |
Consumer Durables |
| Exide Industries Ltd. | 385.10 | |
Automobile & Ancillaries |
| CRISIL Ltd. | 4393.05 | |
Ratings |
| Hindustan Petroleum Corporation Ltd. | 385.60 | |
Crude Oil |
| Steel Authority Of India Ltd. | 169.80 | |
Iron & Steel |
| Godfrey Phillips India Ltd. | 1775.00 | |
FMCG |
| Godrej Industries Ltd. | 952.85 | |
Chemicals |
| Kansai Nerolac Paints Ltd. | 200.50 | |
Chemicals |
| LIC Housing Finance Ltd. | 552.00 | |
Finance |
| The Ramco Cements Ltd. | 842.55 | |
Construction Materials |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 25044.65 | 26373.20 | 22179.90 |
| Nifty IT | 32468.95 | 40301.40 | 25699.10 |
| Nifty Next 50 | 72789.45 | 75000.40 | 59896.10 |
| NIFTY50 USD Index | 9237.8 | 10443.40 | 7839.85 |
| Nifty Bank | 59741.25 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 61022.55 | 64450.90 | 52032.85 |
| Nifty 500 | 23567.0 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17589.5 | 18500.95 | 14804.55 |
| Nifty 100 | 25992.95 | 26975.15 | 22720.45 |
| Nifty FMCG | 46660.65 | 55897.55 | 42006.00 |
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mphasis has informed that it enclosed the transcript of the Investors/Analysts Earnings Conference Call held on Friday, November 6, 2026, in connection with the financial results of the Company for the quarter and half year ended September 30, 2026. The transcript is also uploaded on the website of the Company and can be accessed at the weblink: https://www.mphasis.com/content/dam/mphasis-com/global/en/investors/financial-results/2027/transcriptof-earnings-call-q2-2027.pdf. The above intimation is also available on the website of the Company at: www.mphasis.com.
Gland Pharma has informed that, Xiao Le has been appointed as the Chief Investment Officer of Gland Pharma International, (‘Gland Singapore’) the Wholly-owned subsidiary of the Company, effective November 09, 2026. Xiao Le will be responsible for exploring various investment opportunities and to improve M&A capability for Gland in the United States of America, China, Singapore and other countries. Xiao Le shall be reporting to the CEO of Gland Singapore. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are given in Annexure-A enclosed.
The above information is a part of company’s filings submitted to BSE.
In continuation to its previous intimation Ref. No.: GIC-HO/BOARD/SE-Q2-IMC/269/2026- 27 dated 3rd November 2026, General Insurance Corporation of India has informed that the Corporation has conducted earnings call with analysts and investors on 6th November 2026 on the Unaudited Standalone and Consolidated Financial Results of the Corporation for the period ended 30th September 2026. The audio recording of the said call is available on the website of the Corporation at: https://www.gicre.in/images/audio/GICRe%20Q2FY27%20Earnings%20Call%20Audio% 20File.mp3. This is pursuant to and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and applicable laws.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of MIDCAP index is ₹44246.27 as of 2026-01-23.
The total volume of MIDCAP index is 55941771.00 as of 2026-01-23.
The percentage change in value of MIDCAP index is -1.56% as of 2026-01-23.
The absolute increase in MIDCAP index value since the previous trading day is ₹-699.21 as of 2026-01-23.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
The BSE Midcap Index is a benchmark index that tracks the performance of mid-sized companies listed on the Bombay Stock Exchange (BSE). It represents companies that fall between large-cap and small-cap categories in terms of market capitalisation.
The BSE Midcap Index tracks the performance of mid-cap companies listed on the BSE. It is commonly used to monitor the performance of the mid-cap segment of the Indian stock market.
The commonly used index name and symbol is BSE MIDCAP or BSE MidCap Index.
The BSE Midcap Index includes companies from various sectors such as financial services, industrials, healthcare, consumer goods, information technology, energy, and others. The sector composition changes based on the index methodology and periodic reviews.
The BSE Midcap Index focuses on mid-sized companies, whereas the BSE Sensex tracks 30 of the largest and most established companies listed on the BSE. As a result, the BSE Midcap Index represents the mid-cap segment, while the Sensex reflects large-cap market performance.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.